B Group, Inc.
Top Portfolio Positions
20 positions ·
$134,887,408 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ADMA |
Adma Biologics, Inc.
Healthcare
|
3,207,542 | $28,899,953 | 21.43% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
11,414,285 | $19,974,998 | 14.81% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
33,237 | $10,708,629 | 7.94% | |
| CLLS |
Cellectis S.A.
Healthcare
|
3,281,501 | $10,402,358 | 7.71% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
450,646 | $8,476,651 | 6.28% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
1,800,556 | $8,048,485 | 5.97% | |
| NRXP |
NRX Pharmaceuticals, Inc.
Healthcare
|
3,000,000 | $6,390,000 | 4.74% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
127,500 | $6,145,500 | 4.56% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
1,500,000 | $5,265,000 | 3.90% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
100,000 | $5,044,000 | 3.74% |
Portfolio Trend
6 quarters · across all stocks
Holdings in NRXP
Shares Held
Position Value (USD)
2 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,390,000 | 3,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-08-18 | $8,280,000 | 3,000,000 | Shares | Sole | 2025-08-21 | |
| No 13F history on record for this holder in this stock. | ||||||